Erbitux cetuximab: Start Phase III

IMCL and BMY will start this month the Phase III IMCL-0452 trial in

Read the full 136 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE